TWST Prakiraan rega marang bathi Twist Bioscience Inc
Twist Bioscience (TWST) strives for global leadership in synthetic biology by leveraging silicon platforms for DNA data storage. The business's forward P/E clearly demonstrates market expectations, with the ratio currently standing at 0.00. High process automation minimizes human error, while an eco-friendly approach reduces plastic and chemical consumption, driving a breakthrough in medicine.
Rincian analitis lan laporan data perusahaan Twist Bioscience Corp (TWST)
- nilai saham lan prakiraan konsensus rega:
- data kapitalisasi pasar:
- statistik nilai buku emiten:
- informasi babagan utang lan solvabilitas:
Total Utang marang Modal Twist Bioscience|TWST - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Twist Bioscience|TWST - Utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku Twist Bioscience Inc|TWST - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan Twist Bioscience|Rasio cepet twistbioscience.com
- rincian asil keuangan lan kelipatan valuasi:
TWST - Asil keuangan resik|Proyeksi bathi mangsa ngarep Twist Bioscience|TWST - Kapitalisasi marang bathi|Rega marang bathi mangsa ngarep Twist Bio|TWST - Rasio P/E diaturake wutah|Pangali EV/EBITDA Twist Bioscience Inc|TWST - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) Twist Bioscience|TWST - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan twistbioscience.com|TWST - Wutah bathi resik saben siji saham kanggo taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Twist Bioscience
Analisis kabeh metrik perusahaan:TWST Twist Bioscience, Inc.
Twist Bioscience (TWST) combines proprietary DNA synthesis with multi-cloud hosting to minimize infrastructure risks. The ratio of the current market price to expected annual net income determines the asset's calculated value. This metric allows investors to assess the premium paid for future growth. Low values signal undervaluation but may indicate a value trap. The dynamics of these processes are reflected in the company's forward P/E for the coming year.
Pesaing utama
Rega marang bathi mangsa ngarep Tempus Labs (TEM)|Kapitalisasi marang proyeksi bathi Qiagen NV|Ionis Pharma - Prakiraan rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep RGEN (Repligen Inc.)|RNA: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi CRSP (crisprtx.com)|WGS: Pangali Forward P/E|RARE (Ultragenyx Pharmaceutical Inc.) - Rega marang bathi mangsa ngarep|BEAM (Beam Therapeutics Corp) - Pangali Forward P/E|Sarepta Corp (SRPT) - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep 10x Genomics, Inc. (TXG)|NTLA - Rasio prakiraan rega marang bathi|Rega marang bathi mangsa ngarep Stoke Therapeutics, Inc. STOK|Kapitalisasi marang proyeksi bathi BioLife Solutions Inc (BLFS)|Wave Life Sciences Corp - Pangali Forward P/E|Maze Therapeutics Corp (MAZE) - Prakiraan rega marang bathi|SION: Pangali Forward P/E|PRME - Kapitalisasi marang proyeksi bathi|TSHA (Taysha Gene Therapies, Inc.) - Pangali Forward P/E|Rasio prakiraan rega marang bathi uniQure NV QURE|Rega marang bathi mangsa ngarep MeiraGTx PLC (MGTX)|REGENXBIO Corp - Rasio rega marang bathi mangsa ngarep|Pangali Forward P/E SLDB (Solid Biosciences Inc.)|OCGN - Prakiraan rega marang bathi|PacBio - Pangali Forward P/E|Rasio prakiraan rega marang bathi Benitec Biopharma Inc|DSGN (Design Pharma) - Prakiraan rega marang bathi|RCKT: Rasio kapitalisasi marang bathi mangsa ngarep|Prakiraan rega marang bathi FDMT|Prakiraan rega marang bathi Lexeo (LXEO)|Rega marang bathi mangsa ngarep Korro Bio, Inc. (KRRO)|Kapitalisasi marang proyeksi bathi Editas Medicine Inc|Silence Therapeutics Inc. - Prakiraan rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep PRQR (ProQR)|Codexis Bio - Pangali Forward P/E|SGMO (sangamo.com) - Rasio rega marang bathi mangsa ngarep|nautilus.bio (NAUT) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi mangsa ngarep MGX|DTIL (Precision BioSciences, Inc.) - Pangali Forward P/E|Pangali Forward P/E Generation Bio Corp|Prakiraan rega marang bathi BOLD (Boundless Bio, Inc.)|Rasio kapitalisasi marang bathi mangsa ngarep XCUR|Imunon - Prakiraan rega marang bathi|PHIO - Prakiraan rega marang bathi|Mustang Bio Corp - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi TransCode Therapeutics RNAZ|bionanogenomics.com (BNGO) - Rega marang bathi mangsa ngarep|APDN - Kapitalisasi marang proyeksi bathi|Prakiraan rega marang bathi BLUE|IPA (ImmunoPrecise) - Rasio kapitalisasi marang bathi mangsa ngarep|Prakiraan rega marang bathi OMGA (Omega)|OMIC (Singular Genomics Corp) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E RGLS (Regulus Therapeutics)|syros.com - Rega marang bathi mangsa ngarep|Telesis Bio - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi TRACON Pharmaceuticals Inc. TCON|Unity Bio (UBX) - Rega marang bathi mangsa ngarep
